NCT05979363
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China
Clinical trial condition
Plasma Cell Leukemia
Explore clinical trials studying Plasma Cell Leukemia. Study availability and eligibility vary by location and protocol.
34 public trials
16 recruiting studies
Plasma Cell Leukemia trial results
Recruiting
A Study of CT0596 in Plasma Cell Leukemia
NCT06988059
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Recruiting
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT05219721
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Recruiting
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT05759793
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine Shanghai, China
NCT06045091
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
NCT05283993
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
- Locations
-
- Peking University First Hospital Beijing, China
Not Yet Recruiting
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
NCT07605416
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
Not Yet Recruiting
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT06655519
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
Not specified
Not Yet Recruiting
Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
NCT05054478
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
Not specified
NCT02722668
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Myeloid Leukemia, +74 more
- Locations
-
- Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States